Emgality Eiropas Savienība - slovāku - EMA (European Medicines Agency)

emgality

eli lilly nederland b.v. - galcanezumab - poruchy migrény - analgesics, galcanezumab - emgality je indikovaný na profylaxiu migrény u dospelých, ktorí majú aspoň 4 migréna dní za mesiac.

VELBIENNE 2 mg/1 mg filmom obalené tablety Slovākija - slovāku - ŠÚKL (Štátny ústav pre kontrolu liečiv)

velbienne 2 mg/1 mg filmom obalené tablety

exeltis slovakia s.r.o., slovensko - dienogest a estrogén - 56 - hormona (lieČiva s hormonÁlnou aktivitou)

KESTREL Slovākija - slovāku - myHealthbox

kestrel

bayer ag - kvapalný koncentrát - acetamiprid 200g/l

KESTREL Slovākija - slovāku - myHealthbox

kestrel

bayer ag - kvapalný koncentrát - acetamiprid 200g/l

Ajovy Eiropas Savienība - slovāku - EMA (European Medicines Agency)

ajovy

teva gmbh - fremanezumab - poruchy migrény - calcitonin gene-related peptide (cgrp) antagonists - ajovy je indikovaný na profylaxiu migrény u dospelých, ktorí majú aspoň 4 migréna dní za mesiac.

Vyepti Eiropas Savienība - slovāku - EMA (European Medicines Agency)

vyepti

h. lundbeck a/s - eptinezumab - poruchy migrény - analgetiká - vyepti is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.

Vydura Eiropas Savienība - slovāku - EMA (European Medicines Agency)

vydura

pfizer europe ma eeig  - rimegepant - poruchy migrény - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.

Rayvow Eiropas Savienība - slovāku - EMA (European Medicines Agency)

rayvow

eli lilly nederland b.v. - lasmiditan succinate - poruchy migrény - analgetiká - rayvow is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.

Pombiliti Eiropas Savienība - slovāku - EMA (European Medicines Agency)

pombiliti

amicus therapeutics europe limited - cipaglucosidase alfa - glykogénová choroba typu ii - iné alimentárny trakt a metabolizmus výrobky, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).

Aquipta Eiropas Savienība - slovāku - EMA (European Medicines Agency)

aquipta

abbvie deutschland gmbh & co. kg - atogepant - poruchy migrény - aquipta is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.